Forgot your password?
ECCO General Assembly
ECCO Governing Board
The Council of National Representatives
ECCO Operational Board
Affiliate ECCO Societies & ECCO Partners
ECCO & IBD
Congresses & Events
15th Congress of ECCO, Vienna 2020
14th Congress of ECCO, Copenhagen 2019
13th Congress of ECCO, Vienna 2018
12th Congress of ECCO, Barcelona 2017
11th Congress of ECCO, Amsterdam 2016
10th Congress of ECCO, Barcelona 2015
9th Congress of ECCO, Copenhagen 2014
8th Congress of ECCO, Vienna 2013
7th Congress of ECCO, Barcelona 2012
6th Congress of ECCO, Dublin 2011
ECCO Educational Workshops
IBD Nurse Education Programme
ECCO: EduCational COurse for Industry
Guideline Methodology and GRADE Workshop
H-ECCO IBD Masterclass
IBD Intensive Advanced Course
N-ECCO Network Meeting
N-ECCO Research Forum
P-ECCO Educational Course
School for Clinical Trialists
S-ECCO IBD Masterclass
Y-ECCO Basic Science Workshop
Y-ECCO Career Workshop
Fellowships and Grants
ECCO CONFER Cases
ECCO Topical Review
Published ECCO Topical Reviews
Published ECCO Guidelines
Letters from the President
ECCO Country Member Profiles
ECCO-EFCCA Patient Guidelines
CD Patient Guidelines
UC Patient Guidelines
Press & Awareness
EU Research Projects
FP7 Sadel Project
Horizon 2020 - BIOCYCLE Project
Poster presentations: Clinical: Diagnosis & outcome (2015)
in the Abstract Database
* = Presenting author
Poster presentations: Clinical: Diagnosis & outcome (2015)
P079 Predicting the risk of acute severe colitis (ASC) at diagnosis of Ulcerative Colitis (UC): external validation
P080 Persistence and sensitivity of colonic biopsies for microscopic colitis in a regional cohort
P081 Matrix Metalloproteinase Degraded Biglycan (BGM) and Citrullinated and MMP-degraded Vimentin (VICM) differentiates Crohn's disease from ulcerative colitis.
P082 The relationship between onset days and clinical characteristics of pouchitis after ileal pouch-anal anastomosis in Ulcerative Colitis
P083 Low-grade Dysplasia in Ulcerative Colitis: Risk Factors associated with Progression to High-grade Dysplasia or Colorectal Cancer
P084 Attributes of anti-TNF treatment that impact on preferences of patients with Crohn's disease candidates for biological treatment (IMPLICA Study)
P085 Pregnancy-onset IBD is not associated with adverse maternal or neonatal pregnancy outcomes
P086 The presence of the Epstein-Barr virus is associated to a higher colectomy requirement in patients with Ulcerative Colitis
P087 The study of the related risk factors of steroid resistance with Ulcerative Colitis in the Chinese Han polulation
P088 Serum Matrix Metalloproteinase-3 Concentration Correlates with Clinical and Endoscopic Evidence of Ulcerative Colitis
P089 Disease course, phenotype, and medication use in elderly-onset Crohn's disease patients - A population-based IBD-SL cohort study
P090 Evaluation of NT-proBNP in Inflammatory Bowel Disease
P091 The impact of a value-based health program for inflammatory bowel disease management on healthcare utilization
P092 Risk factors for active tuberculosis in patients with inflammatory bowel disease: A case-control study
P094 Prediction of patency capsule retention by MR Enterography in patients with known Crohn's disease:
P095 Lewis Score - prognostic value in patients with isolated small bowel Crohn's disease
P096 Transperineal ultrasound: first level exam in the management of perianal disease?
P097 The Thromboembolism in Inflammatory Bowel Disease - apropos of 28 cases
P098 An endoscopic therapeutic goal to maintain remission with tacrolimus in refractory ulcerative colitis
P099 Efficacy, safety and predictors of response to Adalimumab in Crohn's disease (CD)- a nation-wide cohort study
P100 Motivational interviewing in Inflammatory Bowel Disease patients counselling: Data from a case-control study
P101 Fecal Calprotectin is a valuable marker for detecting active Crohn`s disease with colon involvement
P102 Hemophagocytic lymphohistiocytosis in Crohn's Disease associated to citomegalovirus (CMV) or Epstein-Barr virus (EBV)
P103 Assessment of QOL using internet web system in Japanese patients with Inflammatory Bowel Disease: The 3I survey
P104 Fecal calprotectin as a non-invasive biomarker for intestinal involvement of Behçet's disease
P105 Evaluating the frequency of MEFV gene mutation and its impact on the clinical course in patient with inflammatory bowel disease
P106 Screening for melanoma and non melanoma skin cancer in IBD patients before and after thiopurines and anti-TNFs: A single-center prospective cohort study
P107 Increased prevalence of lower GI tract abnormalities without any IBD in patients with primary biliary cirrhosis
P108 Mean Platelet Volume As An Inflammatory Marker In Inflammatory Bowel Disease
P109 The prevalence of liver, biliary tract and pancreas abnormalities in patients with Inflammatory Bowel Disease screened by US and confimed by echoendoscopy
P110 Usefulness of magnifying endoscopy for diagnosis of colitis-associated intraepithelial neoplasia in patients with ulcerative colitis
P111 Are extraintestinal manifestations associated with disease outcomes in Ulcerative Colitis? Results from a population-based inception cohort between 2002-2012
P112 Effectiveness of "Hospital Anxiety and Depression Scale" for the screening of the psychiatric treatment need in outpatients with Inflammatory Bowel Diseases
P113 Subclinical Ultrasonographic Enthesopathy and Synovitis in patients with Inflammatory Bowel Disease (IBD) without clinical signs or symptoms of Spondyloarthritis
P114 Outcome of thiopurine-intolerant patients with Crohn's disease (CD)
P115 Early and late-onset Crohn's disease: different clinical presentation and course, an Italian cohort study
P116 Serologic and genetic markers may predict the development of chronic pouchitis after pouch surgery in ulcerative colitis patients
P117 Risk matrix for prediction of disease progression in a referral cohort of patients with Crohn's Disease
P118 Incidence and Severity of Pre-pouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory
P119 Evaluation of Crohn's disease: CRP in the midst of MRI and endoscopy
P120 Consistently low albumin level is associated with subsequent bowel stenosis, fistula or perforation in patients with Crohn's disease.
P121 Delay in diagnosis of Crohn's disease: description over time and identification of associated factors. A 21-year population based study
P122 Rectal bleeding accurately reflects mucosal inflammation in patients with Ulcerative Colitis
P123 A single center experience with small bowel capsule endoscopy for patients with established Crohn's Disease: In which patients are lesions found?
P124 Iron deficiency in the absence of anemia affects the perception of health-related quality of life in IBD patients in remission
P125 Developments of novel diagnostic findings on capsule endoscopy in the small bowel of patients with Crohn's disease
P126 Clinical Predictors at Diagnosis for Disabling Crohn's Disease in Korea : Results from the CONNECT Study
P127 Clinical outcomes of ileocaecal Crohn's disease: Surgery versus pharmacotherapy
P128 A new chemiluminescent immunoassay for measurement of Calprotectin in stool
P129 Systematic evaluation of clinical predictors of aggressive ulcerative colitis
P130 Persistent Enhancement in Contrast Ultrasound Studies of Severe Crohn's Disease: Stuck Bubbles?
P131 High prevalence of Inflammatory Bowel Disease like findings in endoscopic and pathological samples of patients with common variable immunodeficiency
P132 Could the cytokines concentration be a marker of IBD activity and be usefull in evaluation of IBD differentiation?
P133 Frequency of fecal incontinence and factors associated with its development in patients with Inflammatory Bowel Disease
P134 Clinical, Morphological and Histological Features of X-linked Lymphoproliferative Syndrome Type 2 Enteritis Diagnosed in three Cases with Childhood Onset Inflammatory Bowel Disease
P135 Diagnostic delay in IBD- Evaluation of risk factors
P136 Usefulness of serum IL-32 and IL-33 as a predictor of clinical course in Crohn's disease
P137 5 year budget impact analysis of CT-P13 (Infliximab) for the treatment of Crohn's Disease in UK, Italy and France
P138 Health Quality and Sexual Dysfunction in Turkish IBD Patients
P139 Predictive Factors for Differentiating between Crohn's disease and Intestinal tuberculosis in Korea
P140 Proximity Extension Assay technology identifies novel serum biomarkers for predicting Inflammatory Bowel Disease: IBD Character Consortium
P141 Presence of anaemia is an indicator of long-term disease course in Inflammatory Bowel Diseases. Results from a population-based inception cohort
P142 Quantification of inflammation in small bowel Crohn's disease (SBCD) patients by videocapsule endoscopy (VCE) and magnetic resonance enterography (MRE)
P143 The Usefulness of Ultra-low Dose CT colonography for Assessing Mucosal Inflammation in Patients with Ulcerative Colitis
P144 Characterisation of incident cases of cancer in Inflammatory Bowel Disease: A prospective multicenter nested case-control IG-IBD study
P145 Fecal calprotectin correlates with inflammatory disease activity as seen on CT imaging of the small bowel better than clinical assessment
P146 Detection and characterization of colonic dysplastic lesions in IBD surveillance colonoscopy - a randomised comparison of high definition alone with high definition dye spraying and electronic virtual chromoendoscopy using iSCAN
P147 Usefulness of fecal S100A12 in defining mucosal healing in Ulcerative Colitis
P148 Immunohistochemical staining of plasma cells and eosinophils in Inflammatory Bowel Disease: a preliminary report.
P149 Clinical Characteristics and Prognosis of Crohn's Disease Patients with Jejunal Involvement in Korea: Results from the CONNECT Study
P150 The influence of different information sources, disease related knowledge and anxiety in patients with IBD
P151 Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort
P152 Ultrasound elasticity imaging accurately quantifies ileal fibrosis in patients with Crohn's Disease
P153 Small bowel cleansing does not improve quality of wireless capsule endoscopy
P154 Identifying predictors of low adherence in patients with Inflammatory Bowel Disease
P155 Comparison of video capsule endoscopy and faecal calprotectin as diagnostic tools in patients with abdominal symptoms suggestive of small bowel Crohn's Disease
P156 Comparison of fetal risks in pregnancy before and after diagnosis of Inflammatory Bowel Disease: A prospective study
P157 A randomised, assessor-blinded, multicentre trial (OPTIMA) investigating the efficacy, safety and tolerability of a novel tailored split-dosing schedule for colon cleansing in preparation for colonoscopy
P158 Short-term MRE predictors of need in Crohn's disease related surgery
P159 Transabdominal ultrasound has high negative predictive value for short-term complications of Inflammatory Bowel Disease
P160 Need for Recurrent Resection and Complex Phenotype are Associated with a Specific Antibody Signature in Crohn's Disease Patients undergoing Resection. Smoking is Not Associated with Prevalent Antibodies. Prognostic and Mechanistic Implications.
P161 Validation of a risk score predicting post-surgical complications in patients with inflammatory bowel diseases
P162 Is Sensorineural Hearing Loss Frequent in Patients With Inflammatory Bowel Disease? Preliminary Results Of Ongoing Study
P163 Where do patients go for information on Inflammatory Bowel Disease (IBD)?
P164 Evaluation of an interim Crohn's disease outcome measure (PRO-2) based on two patient-reported components (stool frequency, abdominal pain) of the Crohn's Disease Activity Index (CDAI) in the ustekinumab CERTIFI Study
P165 The distribution and severity of small bowel inflammatory activity forecast the emergence of anemia and nutricional deficits in Crohn's Disease
P166 Upper gastrointestinal involvement in asymptomatic Crohn's disease patients in two countries of emerging disease: Asia and Eastern Europe
P167 Prolonged Small Intestinal Transit in Crohn's Disease is associated with a history of stricturing and penetrating disease.
P168 Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease
P169 Exhaled volatile organic compound breath analysis in Inflammatory Bowel Disease
P170 Comparison between elderly onset and adult onset inflammatory bowel disease
P171 Smoking is associated with watery diarrhea and decreased likelihood to achieve clinical remission in collagenous colitis
P172 Clinical and biological predictors of fatigue in Inflammatory Bowel Disease patients
P173 Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study
P174 Diagnostic value of a novel combination score of disease activity in a real-life IBD cohort.
P175 Clinical outcome of ulcerative colitis with mucosal healing demonstrated by white light endoscopy but with subtle abnormalities detected by high definition iSCAN endoscopy
P176 Irritable bowel syndrome frequency in Inflammatory Bowel Disease during both clinical and deep remission and its association with fecal calprotectin
P177 Patency capsule in patients with established Crohn's disease undergoing videocapsule endoscopy of the small bowel
P178 Association between eleven thiopurine metabolites and mucosal healing in patients with Crohn's disease
P179 Serum amyloid A level correlated with endoscopic findings in patients with Crohn's disease - possible biomarker for evaluating mucosal healing
P180 The new faecal marker matrix metalloprotease-9 is more sensitive for postoperative endoscopic recurrence than fecal calprotectin in Crohn's disease
P181 Diagnostic performance of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) in the evaluation of stenosis and endoscopic recurrence in Crohn's disease
P182 New risk score for prediction of relapse in patients with Ulcerative Colitis, Results of a prospective cohort study
P183 Diagnostic value of fecal gelatinase-associated lipocalin as a surrogate marker of inflammation in Inflammatory Bowel Diseases
P184 Simplifying the meaning of small bowel thickening
P185 Multidisciplinary approach in IBD patients with arthralgias: Usefulness of a combined reumatologic and gastroenterologic assessment in a prospective study
P186 Pregnancy and natural history of Inflammatory Bowel Disease
P187 Hearing loss in patients with Inflammatory Bowel Disease
P188 Diagnostic yield of MR enterography versus Wireless Video Capsule Endoscopy in suspected small bowel paediatric Crohn's disease
P189 Latent tuberculosis: Diagnostic value of QuantiFERON and genetic association to the SNP INFG+874 T/A
P190 Computed tomography enterography and biomarkers in detecting active and complicated small bowel Crohn's Disease
P191 Effects of CT reconstruction algorithm on the quantitative assessment of Crohn's Disease: A comparison of standard and low dose CT enterography
P192 Prevalence and causes of anaemia in patients with Inflammatory Bowel Diseases in Southern Italy
P193 Temporal change in phenotypic behaviour in patients with Crohn's Disease
P194 The Assessment of Disease Activity by Quantitative Fecal Immunochemical Test in Ulcerative Colitis
P195 Bone metabolic disease in Inflammatory Bowel Disease patients with past or current corticosteroid treatment
P196 Fatigue Severity and Factors Associated with High Fatigue Levels in Tunisian Patients with Inflammatory Bowel Disease
P197 Retrospective Analysis of Enterocutaneous Fistula Management in IBD
P198 Ionizing radiation exposure in patients with inflammatory bowel disease: Are we overexposing our patients?
P199 Identification of risk factors of colitis-associated carcinoma in Japanese patients with Ulcerative Colitis: Results from a retrospective multicenter study in a Kyoto-Shiga cohort
P200 Definitions of the endoscopic lesions in Crohn's disease: reproductibility study and GETAID expert consensus.
P201 Reproducibility of magnetic resonance enterography assessment of disease activity in Crohn's Disease using central readers
P202 Outcomes of a large cohort of children with IBDU compared to other IBD subtypes and treatment options- a longitudinal report from the Porto pediatric IBD group of ESPGHAN
P203 Contrast-enhanced ultrasonography in the evaluation of Crohn's disease activity: correlation with ileocolonoscopy
P204 Small bowel mucosal healing and deep remission in patients with known small bowel Crohn's disease.
P205 Ionizing radiation throughout the duration of immunosuppression therapy in Crohn's disease: should it remain a concern?
P206 Prevalence and risk factors for thromboembolic complications in IBD patients
P207 Serological Antibodies for the Prediction of Post-operative Recurrent Crohn's Disease. Results from the POCER study
P208 Patient-reported outcomes in biologic and thiopurine treatment of IBD measured as HRQoL and symptoms
P209 Impact of perineal fistulization on behavior characteristics of intestinal crohn's disease
P210 Calprotectin predicts relapse of IBD even in the presence of a 'normal' colonoscopy
P211 Gender-related differences in work productivity impairment and quality of life in Inflammatory Bowel Disease (IBD): A cross-sectional survey from Southern Italy
P212 Serum biomarkers predict disease severity in Ulcerative Colitis
P213 A systematic review and meta-analysis of non-invasive biomarkers for assessing disease activity in Inflammatory Bowel Disease
P214 Ulcerative Proctitis: Predictors and outcomes of disease extension in UC
P215 Correlation of histological activity and basal plasmacytosis with mucosal healing in ulcerative colitis patients
P216 Defensins alpha 5 and 6 are up-regulated in the colonic mucosa from patients with Ulcerative Colitis and are associated with clinical outcomes
P217 The use of imaging techniques in the diagnosis and management of Crohn's Disease: Results of a national survey (Raymond study) aimed at Spanish gastroenterologists and radiologists
P218 Vitamin D status in IBD patients: a comparison of three different assays
P219 The relevance of ileitis as diagnosed by capsule endoscopy: A comparison with double balloon enteroscopy
P220 Diagnostic challenges in inflammatory bowel disease: fully automated immunoassay profiling of fecal biomarkers
P221 Evolution of serological markers and their predictive value before and after right hemicolectomy with ileocolonic anastomosis in patients with Crohn's disease
P222 Delay in Meeting Diagnostic Criteria in Crohn's Disease.
P223 Idelalisib-induced acute proctocolitis: Clinical and histological findings
P224 The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) is useful to evaluate endoscopic improvement and to predict medium-term prognosis in ulcerative colitis patients treated with tacrolimus.
P225 Anticipate to defer: predicting surgical outcome at the moment of diagnosis of Crohn's disease
P226 Consistently high C reactive protein is associated with subsequent development of perianal fistulae in patients with Crohn's disease.
P227 Lower serum albumin level on admission is a predictive factor of colectomy in patients with moderate to severe ulcerative colitis
P228 Vaginal delivery is not associated with fecal incontinence in IBD women
P229 AlphaE (±E) integrin protein and gene expression are augmented in the ileum relative to the colon in Crohn's disease
P230 ECCO endoscopy consensus for Inflammatory Bowel Disease and daily clinical practice: A need for dedicated training
P231 Diagnostic delay is associated with higher rate of major surgery in a French prospective cohort of patients with Crohn's Disease
P232 Real-time Shear Wave Ultrasound Elastography in distinguishing inflammatory from fibrotic stenosis in Crohn's disease
P233 Risk factors and clinical signicance of endoscopic entent progression in patients with Ulcerative Colitis
P234 Development of a patient reported disease activity score to screen for mucosal inflammation in inflammatory bowel disease.
P235 Clinical utility of the Lémann index and Rutgeerts score to predict postoperative course of Crohn's disease: a retrospective single-center cohort study.
P236 Placebo response and remission rates in Ulcerative Colitis clinical trials: Systematic review and meta-analysis
P237 Accuracy of a rapid fecal calprotectin test as a predictor of mucosal healing in patients with Ulcerative Colitis (UC)
P238 Accuracy of fecal calprotectin predicting endoscopic activity in Inflammatory Bowel Disease patients
P240 Correlation between the Ulcerative Colitis Endoscopic Index of severity (UCEIS) and intestinal mucosal calprotectin (IMC) in acute severe ulcerative colitis.
P241 Limitations in using fecal Calprotectin as a biomarker of IBD disease activity during Pregnancy
P242 Length of small bowel resection, SeHCAT retention value and frequency of diarrhoea: is there a link?
P243 Prevalence of extraintestinal manifestations in paediatric patients with Inflammatory Bowel Disease: Results from the Swiss IBD Cohort Study
P244 Performance of Tuberculin skin test in routine screening for latent tuberculosis infection in patients with inflammatory bowel diseases
P245 Accuracy of fecal M2-Pyruvate Kinase compared with fecal calprotectin to assess endoscopic severity in patients with inflammatory bowel diseases
P246 Intracavitary contrast-enhanced ultrasound in evaluating fistula of Crohn's Disease: a preliminary study
P247 C-reactive protein is elevated with clinical disease activity during pregnancy in women with Inflammatory Bowel Disease
P248 Non-invasive Methods for monitoring mucosal healing in paediatric ulcerative colitis with usage of faecal calprotectin.
P249 Worries in IBD patient relatives. Why and how much do they worry?
P250 Validation of the Portuguese version of a questionnaire for the assessment of healthcare quality from the point of view of a patient with inflammatory bowel disease (QUOTE-IBD)
P251 Diagnostic delay in IBD: a comparison in the last thirty years, an Italian multicentric study
P252 Fulminant hepatic failure requiring transplantation after initiation of infliximab therapy in Ulcerative Colitis
P253 De novo Inflammatory Bowel Disease following paediatric liver transplantation: A case series of three patients and world literature review
P254 Use of immunomodulators reduces early readmission in patients admitted to hospital with an acute flare of inflammatory bowel disease.
P255 Proximal extension rate of distal disease in Ulcerative Colitis
P256 Characterization of de novo colonic stricture due to Crohn's Disease
P257 Data on Surgery in Paediatric IBD (pIBD) over a 4 year period using the ImproveCareNow (ICN) Collaboration data base
P258 Prevalence of anemia at presentation in pediatric Crohn's Disease patients: single center experience
P259 Improvement of Patient's Disease Activity in Paediatric Inflammatory Disease (pIBD) after adoption of ImproveCareNow (ICN) Quality Improvement (QI) Tool
P260 Virtual chromoendoscopy with FICE is superior to standard colonoscopic surveillaillance for flat visibile dysplasic lesions and raised lesions (polyps and pseudopolyps) evaluation in long-standing ulcerative colitis: a prospective, randomized, trial.
P261 Diagnostic performance of the Simple Clinical Colitis Activity Index (SCCAI) in Ulcerative Colitis (UC) self-administered by the patient at home through an on-line platform compared with the onsite evaluation by a gastroenterologist. CRONICA-UC study
P262 Protein biomarker measurement in non-invasively collected colonic mucus samples as a new approach to inflammatory bowel disease (IBD) detection.
P263 Agreement between on-line patient reported and onsite physician assessed activity on the Simple Clinical Colitis Activity Index (SCCAI) domains. CRONICA-UC study
P264 Revised Predictive Values for IBD Colitis-associated Neoplasia in the Modern Era
P265 Decreased plasma ADAMTS13 antigen and ADAMTS13 activity as a risk factor for hypercoagulability in patients with ulcerative colitis.
P266 Assessing fatigue in Inflammatory Bowel Disease comparison and validation of three fatigue scales: IBD-F, MFI and MAF scales
P267 Long-term outcomes after restorative proctocolectomy and ileal pouch anal anastomosis in paediatric patients; more than 20 years of experience in a tertiary care facility
P268 Hospitalisation and surgery risk in Crohn's disease in the biological era - Results from the Dutch population-based IBD-SL cohort
P269 Serum neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 (NGAL-MMP-9) complex as a surrogate marker for mucosal healing in patients with Crohn's disease.
P270 Maintenance of remission after prolonged therapy with Infliximab: a "real-life" experience from a single Italian centre in patients affected by Crohn's Disease and Ulcerative Colitis
P271 Ulcerative colitis patients undergoing pouch surgery due to non-refractory disease have a better outcome compared to those operated due to refractory inflammation
P272 A pilot study assessing the viability of the Pillcam Colon 2 capsule as a "one-stop" pan-endoscopic test for patients with Crohn's Disease
P273 Validation of a smartphone-based patient monitoring system measuring Calprotectin as the therapy follow-up marker
P274 Diagnostic accuracy of fecal calprotectin and M2-pyruvate kinase in the prediction of endoscopic activity Crohn's disease
P275 Relevance of ultrasonographic parameters in predicting inflammatory bowel disease in a pediatric population.
P276 Evaluation of histological parameters in patients with clinical remission of ulcerative colitis
P277 S. Jiménez*1, V.M. Navas2, J. Martín-De-Carpi3, A. Rodríguez4, S. López-Cuesta5, Ó. Segarra6, J.I. García-Burriel7, E. Donat8, J. Barrio9, V. Crujeiras10, H. Armas11, L. Ortigosa12, R. García-Romero13,
P278 THIOPURINES AND ANTI-TNFS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND A POSITIVE HISTORY OF CANCER
P279 Fecal calprotectin is elevated with clinical disease activity during pregnancy in women with Inflammatory Bowel Disease
P280 Comparison of MR enteroclysis and MR enterography findings with endoscopic findings in paediatric patients with small bowel disease
P281 Diverticular disease-associated segmental colitis and inflammatory bowel disease: a new subgroup of patients?
P282 Fecal calprotectin is correlated to Seo index in prediction of relapse in Iranian patients with Ulcerative Colitis
P283 Effectiviness of fecal calprotectin measurement determining deep remission in Inflammatory Bowel Disease
P284 Surveillance for dysplasia in IBD: are we doing it right? Results from our daily practice
P285 A novel scoring system for differential diagnosis between Crohn's disease and intestinal tuberculosis: A prospective study
P286 Prevalence of Ulcerative Colitis and Crohn ileocolitis in patients with celiac disease
P287 Serologic responses to microorganisms in IBD patients - a prospective longitudinal study
P288 Vitamin B12 deficiency in patients with ileal resection for Crohn's disease: Frequency and predictive factors